These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29490363)

  • 21. [Oral contraceptives and breast cancer].
    Haga S; Kinoshita J
    Nihon Rinsho; 2000 Apr; 58 Suppl():563-5. PubMed ID: 11026050
    [No Abstract]   [Full Text] [Related]  

  • 22. Morphologic features of mammary carcinomas in women taking hormonal contraceptives.
    Gould VE; Wolff M; Mottet NK
    Am J Clin Pathol; 1972 Feb; 57(2):139-43. PubMed ID: 4333281
    [No Abstract]   [Full Text] [Related]  

  • 23. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer risk during hormone therapy: experimental versus clinical data.
    Ruan X; Seeger H; Mueck AO
    Minerva Endocrinol; 2012 Mar; 37(1):59-74. PubMed ID: 22382615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melanoma in female patients: general features and focus on the impact of estro-progestinic pills in prognostic factors.
    Paolino G; Moliterni E; Didona D; Corsetti P; Lopez T; Abbenante D; Calvieri S; Bottoni U
    G Ital Dermatol Venereol; 2018 Aug; 153(4):582-585. PubMed ID: 29767487
    [No Abstract]   [Full Text] [Related]  

  • 26. Choice of contraceptives.
    Med Lett Drugs Ther; 2015 Sep; 57(1477):127-32. PubMed ID: 26353044
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hormonal contraception].
    Van Cauwenberge JR
    Rev Med Liege; 1992 May; 47(5):221-36. PubMed ID: 1604074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Secondary amenorrhea following ovulation inhibitors].
    Kunz J; Keller PJ
    Schweiz Med Wochenschr; 1974 Jun; 104(26):923-7. PubMed ID: 4422939
    [No Abstract]   [Full Text] [Related]  

  • 29. [A further case of hepatocytic adenoma following oestrogen-progestogen treatment. Review of the published literature (author's transl)].
    Grandjean JP; Vignal J; Seffert P; Mestrallet G; Beurlet J; Quiviger P
    Ann Chir; 1979 May; 33(5):361-70. PubMed ID: 389138
    [No Abstract]   [Full Text] [Related]  

  • 30. Uptake of the levonorgestrel intrauterine system among recent postpartum women in Kenya: factors associated with decision-making.
    Hubacher D; Masaba R; Manduku CK; Veena V
    Contraception; 2013 Jul; 88(1):97-102. PubMed ID: 23566383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Contraceptives in the perimenopause: Safe prevention and treatment of menopausal symptoms?].
    Zahradnik HP
    Med Monatsschr Pharm; 2010 Apr; 33(4):143-4. PubMed ID: 20429405
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral contraceptives and endometrial and cervical cancer.
    Moghissi KS
    J Toxicol Environ Health; 1977 Sep; 3(1-2):243-65. PubMed ID: 336901
    [No Abstract]   [Full Text] [Related]  

  • 33. An overview of studies on estrogens, oral contraceptives and breast cancer.
    Drill VA
    Prog Drug Res; 1981; 25():159-87. PubMed ID: 6796999
    [No Abstract]   [Full Text] [Related]  

  • 34. Present status of hormonal contraception (COCs).
    Elstein M
    Adv Contracept; 1996 Sep; 12(3):155-66. PubMed ID: 8910657
    [No Abstract]   [Full Text] [Related]  

  • 35. Estrogens, progestogens and breast cancer.
    Sturgis SH
    N Engl J Med; 1969 Oct; 281(18):1014-5. PubMed ID: 5824728
    [No Abstract]   [Full Text] [Related]  

  • 36. Breast cancer and hormonal contraception: Should we rethink our concepts?
    Borges JBR; Torresan RZ
    Rev Assoc Med Bras (1992); 2018 Mar; 64(3):201-203. PubMed ID: 29641773
    [No Abstract]   [Full Text] [Related]  

  • 37. Sex steroids and breast cancer prevention.
    Spicer DV; Pike MC
    J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormonal contraception: noncontraceptive benefits and medical contraindications.
    Rager KM; Omar HA
    Adolesc Med Clin; 2005 Oct; 16(3):539-51. PubMed ID: 16183538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study.
    Dumeaux V; Alsaker E; Lund E
    Int J Cancer; 2003 Jul; 105(6):844-50. PubMed ID: 12767072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advances in hormonal contraception].
    Villanueva Egan LA; Pichardo Cuevas M
    Ginecol Obstet Mex; 2007 Jan; 75(1):35-42. PubMed ID: 17542267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.